webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

4-Pentynoyl-Val-Ala-PAB-PNP

  CAS No.: 1956294-76-0   Cat No.: BADC-01764 4.5  

4-Pentynoyl-Val-Ala-PAB-PNP is an alkyne-functionalized peptide ADC linker enabling click chemistry conjugation and enzyme-triggered payload release in antibody-drug conjugates. Keywords: ADC linker, alkyne linker, peptide linker, click chemistry, enzyme-cleavable.

4-Pentynoyl-Val-Ala-PAB-PNP

Structure of 1956294-76-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C27H30N4O8
Molecular Weight
538.55

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
[4-[[(2S)-2-[[(2S)-3-methyl-2-(pent-4-ynoylamino)butanoyl]amino]propanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
Canonical SMILES
CC(C)C(C(=O)NC(C)C(=O)NC1=CC=C(C=C1)COC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)CCC#C
InChI
InChI=1S/C27H30N4O8/c1-5-6-7-23(32)30-24(17(2)3)26(34)28-18(4)25(33)29-20-10-8-19(9-11-20)16-38-27(35)39-22-14-12-21(13-15-22)31(36)37/h1,8-15,17-18,24H,6-7,16H2,2-4H3,(H,28,34)(H,29,33)(H,30,32)/t18-,24-/m0/s1
InChIKey
HIHCCJAGZUJVAO-UUOWRZLLSA-N

4-Pentynoyl-Val-Ala-PAB-PNP, a synthetic peptide employed in diverse research and diagnostic contexts, offers a plethora of applications. Here are four key applications showcased with a high degree of perplexity and burstiness:

Protease Activity Assays: In protease activity assays, 4-Pentynoyl-Val-Ala-PAB-PNP serves as a ubiquitous substrate facilitating the measurement of specific protease activity within biological samples. By quantifying the cleavage of this substrate, researchers can delve into the intricate realm of protease function, unraveling potential protease inhibitors crucial for advancing drug discovery endeavors.

Biomarker Development: Redefining biomarker development, the synthetic essence of 4-Pentynoyl-Val-Ala-PAB-PNP renders it an optimal candidate for disease biomarkers linked to protease dysregulation. Its utility in diagnostic tests enables the detection of aberrant protease activity in patient samples, serving as a linchpin for the early detection and monitoring of conditions like cancer and inflammatory diseases.

Drug Screening: Within high-throughput screening platforms, 4-Pentynoyl-Val-Ala-PAB-PNP emerges as a pivotal tool for identifying and assessing potential protease inhibitors. By scrutinizing how candidate compounds interact with this peptide substrate, researchers embark on a quest to unearth effective inhibitors that may spearhead drug development, catalyzing the quest for novel therapeutics.

Enzyme Kinetics Studies: Powering enzyme kinetics studies, 4-Pentynoyl-Val-Ala-PAB-PNP unveils the intricate kinetic properties of proteolytic enzymes. Through a meticulous analysis of substrate cleavage rates, researchers unveil critical parameters like Km and Vmax, crucial for characterizing enzyme behavior and optimizing conditions tailored for industrial and medical applications at the forefront of scientific exploration.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Fmoc-PEG2-Val-Cit-PAB-OH | Sco-peg2-NH2 | L-Ornithinamide, N-[2-[2-[2-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)ethoxy]ethoxy]acetyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]- | L-Val-D-Cit-PAB | Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 | Py-MAA-Val-Cit-PAB-MMAE | diMal-O-CH2COOH | MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D | SCO-PEG3-Maleimide | Alkyne-Val-Cit-PAB-FAM | 4-Pentynoyl-Val-Ala-PAB-PNP
Send Inquiry
Verification code
Inquiry Basket